A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health long term and overcoming the clinical challenges of managing wet AMD due to the treatment burden of chronic anti-VEGF injections Patients who received therapeutic doses resulted in stable or improved vision and retinal… Continue reading REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
Category: Newswire
Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments
BOSTON, March 28, 2024 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA’s objectives under its new Ice Control for cold Environments… Continue reading Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments
Gogo Testing for Global Broadband Antenna Achieves Major Milestone
Gogo Galileo Remains on Track for Commercial Launch Later This Year BROOMFIELD, Colo., March 28, 2024 /PRNewswire/ — Gogo Business Aviation (NASDAQ: GOGO) today announced it has achieved another important milestone with its Gogo Galileo global broadband service completing end-to-end connectivity using the HDX antenna on the fully deployed Eutelsat OneWeb Low Earth Orbit (LEO) satellite… Continue reading Gogo Testing for Global Broadband Antenna Achieves Major Milestone
Chris Diehl Returns to 101 Mobility as Director of National Accounts
WILMINGTON, N.C., March 28, 2024 /PRNewswire/ — 101 Mobility, a leading provider of mobility and accessibility solutions, is thrilled to announce the return of Chris Diehl to its Home Office Team. Chris rejoins 101 Mobility in the role of Director of National Accounts, where he will focus on expanding relationships with key entities such as… Continue reading Chris Diehl Returns to 101 Mobility as Director of National Accounts
Allprostar to Showcase its New Camping Series at Hong Kong Global Sources Sports & Outdoor Show 2024
XIAMEN, China, March 28, 2024 /PRNewswire/ — Allprostar(Xiamen) Industrial Co.,Ltd has over 16 years of experience outdoor product development and manufacturing and dedicates to providing high and innovative solutions for enthusiasts. Under our flagship brand COMCOCO and CONCONA for outdoors and COCORICK for stoves, we offer a wide range of outdoor gear, including outdoor folding tables,… Continue reading Allprostar to Showcase its New Camping Series at Hong Kong Global Sources Sports & Outdoor Show 2024
Criteo Secures Its First MRC Accreditation for Retail Media Measurement
Now accredited for impression and click metrics across desktop, mobile web, and mobile in-app environments NEW YORK, March 28, 2024 /PRNewswire/ — Criteo (Nasdaq: CRTO), the commerce media company, today announced it achieved its first-ever accreditation by the Media Rating Council (MRC) for display rendered impression and click advertising metrics across desktop, mobile web, and… Continue reading Criteo Secures Its First MRC Accreditation for Retail Media Measurement
Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue
Company expects to initiate dosing in the Phase 1 study of NST-628 in patients with advanced solid tumors harboring genetic alterations in the MAPK pathway in first half of 2024 CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that the… Continue reading Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue
Moringa Tea Market Booms on Caffeine-Free Energy Boost, Reaching US$ 21,456.10 Million by 2034 | Future Market Insights, Inc.
A new report by FMI highlights the rising popularity of moringa tea due to its health benefits, high nutrient content, and lack of caffeine. These qualities make moringa tea stand out from other teas and are expected to drive market growth in the coming decade. The report goes beyond trends to analyze market drivers, challenges,… Continue reading Moringa Tea Market Booms on Caffeine-Free Energy Boost, Reaching US$ 21,456.10 Million by 2034 | Future Market Insights, Inc.
World Molecular Diagnostics for Cancer Markets, 2023-2024 and 2027 with Profiles of Over 120 Companies
DUBLIN, March 28, 2024 /PRNewswire/ — The “Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027” report has been added to ResearchAndMarkets.com’s offering. Exciting technical developments especially in companion diagnostics, hold the promise of a dynamic, growing and evolving world market where single… Continue reading World Molecular Diagnostics for Cancer Markets, 2023-2024 and 2027 with Profiles of Over 120 Companies
CNFinance Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
GUANGZHOU, China, March 28, 2024 /PRNewswire/ — CNFinance Holdings Limited (NYSE: CNF) (“CNFinance” or the “Company”), a leading home equity loan service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Operational and Financial Highlights Total outstanding loan principal[1] was RMB16.0… Continue reading CNFinance Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results